stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
86.56
2.79
−3.12%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Book value per share
Solventum Corporation's book value per share at the end of fiscal 2025 was 29.0×, up 69.8% from 17.1× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 28.1×. Solventum Corporation ranks 15th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 29.0× | 69.75% |
| FY2024 | 17.1× | (74.71%) |
| FY2023 | 67.6× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 28.1× | 1.22% |
| Jun 2026 | 27.8× | (2.56%) |
| Mar 2026 | 28.5× | (1.64%) |
| Dec 2025 | 29.0× | 1.38% |
| 12 more quarters | Free account |
Book value per share against peers
| Company | Book value per share |
|---|---|
| ALGN Align Technology, Inc. compare | 60.6× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. compare | 42.2× |
| ATR AptarGroup, Inc. compare | 41.5× |
| RGEN Repligen Corporation compare | 37.0× |
| SOLV Solventum Corporation | 28.1× |
| BLCO Bausch + Lomb Corporation compare | 18.2× |
| BAX Baxter International Inc. compare | 12.5× |
| AVTR Avantor, Inc. compare | 8.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Revenue growth
- The full statement